vialroom

#retatrutide 2025-02-18

Tuesday12 messages5 participantstimes are UTC
Highlights from this day
  • split_dose_sam — stepping in 1.7 increments instead of doubling is the only thing i would change if i started again 16:00
  • third_shift — im at 7.5 and the appetite effect is stronger than i expected, normal 16:20
  • third_shift — back after 26 months, has anything actually been published since 16:24

triple agonist yeah

👍1
SD
split_dose_sam15:56

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

💀1

stepping in 1.7 increments instead of doubling is the only thing i would change if i started again

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
TS
third_shift16:20

im at 7.5 and the appetite effect is stronger than i expected, normal

⚠️15

back after 26 months, has anything actually been published since

🧪2😂3📈2

no idea whether the heart rate settles for everyone, mine did and one log isnt data

Sponsored
Reference standardsSigma-Aldrich — certified reference materialsAnalytical standards and reagents for the calibration side of the work. If you are quantifying against nothing, you are not quantifying.Shop standards →